TENAX THERAPEUTICS INC's ticker is TENX and the CUSIP is 88032L100. A total of 42 filers reported holding TENAX THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $905,000 | -23.9% | 390,000 | -16.1% | 0.47% | -40.4% |
| Q2 2016 | $1,190,000 | +16.2% | 465,000 | -6.9% | 0.80% | +24.4% |
| Q1 2016 | $1,024,000 | -42.2% | 499,600 | -7.5% | 0.64% | -13.6% |
| Q4 2015 | $1,771,000 | -7.0% | 540,000 | -15.0% | 0.74% | -21.0% |
| Q3 2015 | $1,905,000 | -18.7% | 635,000 | 0.0% | 0.94% | +0.5% |
| Q2 2015 | $2,343,000 | +18.6% | 635,000 | +4.8% | 0.93% | +1.6% |
| Q1 2015 | $1,976,000 | +16.9% | 606,200 | +37.8% | 0.92% | +7.4% |
| Q4 2014 | $1,690,000 | – | 440,000 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,108,593 | $3,326,000 | 1.32% |
| RA Capital Management | 2,670,300 | $8,011,000 | 1.15% |
| Opaleye Management Inc. | 635,000 | $1,905,000 | 0.94% |
| Broadfin Capital, LLC | 1,968,631 | $5,906,000 | 0.33% |
| SABBY MANAGEMENT, LLC | 2,604,660 | $7,892,000 | 0.32% |
| DAFNA Capital Management LLC | 81,509 | $245,000 | 0.24% |
| ARMISTICE CAPITAL, LLC | 88,739 | $266,000 | 0.09% |
| BOURGEON CAPITAL MANAGEMENT LLC | 17,500 | $52,000 | 0.04% |
| Verition Fund Management LLC | 25,640 | $78,000 | 0.02% |
| COMMERZBANK AKTIENGESELLSCHAFT /FI | 738,592 | $2,216,000 | 0.02% |